NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
-12.31%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.52B
AUM Growth
+$1.52B
Cap. Flow
-$90.4M
Cap. Flow %
-5.96%
Top 10 Hldgs %
80.05%
Holding
36
New
2
Increased
1
Reduced
3
Closed
1

Sector Composition

1 Healthcare 72.83%
2 Communication Services 10.44%
3 Technology 8.46%
4 Consumer Discretionary 1.1%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$355M 23.39% 8,854,255
ARDX icon
2
Ardelyx
ARDX
$1.53B
$178M 11.72% 10,294,096
GRPN icon
3
Groupon
GRPN
$1.06B
$144M 9.49% 44,172,953
SUPN icon
4
Supernus Pharmaceuticals
SUPN
$2.53B
$107M 7.06% 7,641,250
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
$105M 6.91% 1,139,890
DERM
6
DELISTED
Dermira, Inc.
DERM
$81.8M 5.39% 3,506,649
OPWR
7
DELISTED
OPOWER INC COM STK (DE)
OPWR
$80.2M 5.28% 8,997,290
EPZM
8
DELISTED
Epizyme, Inc
EPZM
$66.2M 4.36% 5,149,740
TRVN
9
DELISTED
Trevena, Inc.
TRVN
$49.8M 3.28% 4,811,691
CBIO
10
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$48M 3.16% 8,575,135
NVRO
11
DELISTED
NEVRO CORP.
NVRO
$46.1M 3.04% 993,428
LOXO
12
DELISTED
Loxo Oncology, Inc
LOXO
$31.3M 2.06% 1,792,207
HIVE
13
DELISTED
AEROHIVE NETWORKS, INC.
HIVE
$28M 1.84% 4,681,455
LXRX icon
14
Lexicon Pharmaceuticals
LXRX
$400M
$25.6M 1.69% 2,382,286
TRIV
15
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$19.7M 1.3% 3,945,191
TCON
16
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$18.5M 1.22% 1,889,652
CRCM
17
DELISTED
CARE.COM, INC.
CRCM
$16.8M 1.1% 3,260,989
MM
18
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$14.4M 0.95% 8,224,752
EXEL icon
19
Exelixis
EXEL
$10.1B
$12.4M 0.82% 2,207,000
ZSAN
20
DELISTED
Zosano Pharma Corporation
ZSAN
$8.55M 0.56% 2,158,543
CSBR icon
21
Champions Oncology
CSBR
$93.8M
$8.36M 0.55% +1,562,500 New +$8.36M
CVT
22
DELISTED
CVENT, INC.
CVT
$8.22M 0.54% 244,106
RIGL icon
23
Rigel Pharmaceuticals
RIGL
$697M
$8.01M 0.53% 3,243,150
OREX
24
DELISTED
Orexigen Therapeutics, Inc.
OREX
$7.83M 0.52% 3,709,000
ORKA
25
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
$7.24M 0.48% 1,460,209 -8,761,256 -86% -$43.5M